Torrent Pharmaceuticals announced that its Securities Transfer and Stakeholders Relationship Committee will convene on January 5, 2026, to consider and approve the issuance of secured non-convertible debentures via private placement. This issuance falls within previously approved limits by the company's Board of Directors. Torrent Pharma, a leading Indian pharmaceutical company with a significant market presence in India and internationally, recently reported a 14% year-on-year revenue increase to Rs 3,302 crore for Q2 FY25.